Synthesis of Some Novel Thiazolo[4,5-b]Pyridines and their Tuberculostatic Activity Evaluation

Taras Chaban, Olena Klenina, Iryna Drapak, Volodymyr Ogurtsov, Igor Chaban and Volodymyr Novikov
DOI: 
https://doi.org/10.23939/chcht08.03.287
AttachmentSize
PDF icon full_text.pdf125.09 KB
Abstract: 
Structural modification of 5,7-dimethyl-6-phenylazo-3Н-thiazolo[4,5-b]pyridin-2-one relative to the 3rd position of basic heterocycle allows to use its functionalization as the convenient method for the synthesis of various derivatives and diversification of a series of N3 substituted thiazolo[4,5-b]pyridines. The efficient synthetic protocol for aminomethylation proceeding was developed which led to obtaining a series of novel 3-(phenylamino)-methyl derivatives of 5,7-dimethyl-6-phenylazo-3Н-thiazolo[4,5-b]pyridin-2-one. The conditions for aminomethylation reaction allowing to obtain 3-(phenylamino)-methyl derivatives of 5,7-dimethyl-6-phenylazo-3H-thiazolo[4,5-b]pyridine-2-on, as well as hydrazide and arylidenhydrazide derivatives of (5,7-dimethyl-2-oxo-6-phenilazo-thiazolo[4,5-b]pyridine-3-yl) acetic acid with high yields have been developed. The tuberculostatic activity of the newly synthesized compounds was evaluated in vitro against Mycobacterium tuberculosis H37Rv stain using Lowenstein Jensen's egg medium.
References: 

[1] Saeyd H., Morsy E. and Kotb E.: Sci. Commun., 2010, 40, 2712.

[2] Lee Y., Inhee M.-J. and Yoo K.: Bull. Korean Chem. Soc., 2008, 29, 2331.
https://doi.org/10.5012/bkcs.2008.29.12.2331

[3] Chaban T., Ogurtsov V., Chaban I. et al.: Pharm. Rev., 2011, 2, 10.

[4] Ogurtsov V., Chaban T., Klenina O. et al.: Pharm. Rev., 2013, 1, 11.

[5] Chaban T., Panchuk R., Klenina O. et al.: Biopolym. Cell., 2012, 25, 389.
https://doi.org/10.7124/bc.000075

[6] Chaban T., Ogurtsov V., Chaban I. et al.: Phosphorus Sulfur, 2013, 188, 1611.
https://doi.org/10.1080/10426507.2013.777723

[8] Marzoog S. and Al-Thebeiti: Farmaco, 2000, 55, 109.
https://doi.org/10.1016/S0014-827X(99)00130-5

[9] Walczynski K., Zuiderveld P. and Timmerman H.: Eur. J. Med. Chem., 2005, 40, 15.
https://doi.org/10.1016/j.ejmech.2004.09.010

[10] Rao A., Palani A., Chen X. et al.: Bioorg. Med. Chem. Lett., 2009, 19, 6176.
https://doi.org/10.1016/j.bmcl.2009.09.006

[11] Kulkarni S. and Newman A.: Bioorg. Med. Chem. Lett., 2007, 17, 2987.
https://doi.org/10.1016/j.bmcl.2007.03.066

[12] Lin R., Johnson S., Connolly P. et al.: Bioorg. Med. Chem. Lett., 2009, 19, 2333.
https://doi.org/10.1016/j.bmcl.2009.02.067

[13] Bebernitz G., Beaulieu V., Dale B. et al.: J. Med. Chem., 2009, 52, 6142.
https://doi.org/10.1021/jm900839k

[14] Stefanov O. (Ed.): Doclinichni Doslidzhenniya Likars'kych Zasobiv. Avicena, Kyiv 2001.

[15] Komaritsa I.: Khim. Geterotcycl. Soed., 1968, 3, 436.

[16] Chaban T., Zimenkovskii B., Komaritsa J. et al.: Rus. J. Org. Chem., 2012, 48, 268.
https://doi.org/10.1134/S1070428012020170